News
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could ...
Novavax had expected full approval for broader use by April 1, after the FDA reviewed data from a 30,000-person clinical ...
Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...
The vaccine will only be available to those at high risk from COVID—excluding those who may need it to protect a relative or ...
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...
While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...
The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA vaccines to prevent SARS-CoV-2 infection.
The Food and Drug Administration will soon “unleash a massive framework” for how vaccines are tested and approved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results